Skip to main content
    B

    Beyond Air Inc (XAIR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.21
    +0.11 (+5.24%)

    Market Cap: $2.07M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(14/37)
    Avg Surprise
    -21.66%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-3.30
    Range$-3.89 - $-2.71
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-8.20+59.8%
    60d ago$-8.20+59.8%
    30d ago$-3.31+0.5%
    7d ago$-3.31+0.5%
    Current$-3.30
    Revenue Consensus
    $2M
    Range$2M - $2M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-$-3.30---
    Jun 26
    Reported Aug 13
    		$11.00$-8.60+227.91%Beat+819.0%
    Mar 26
    Reported Jun 26
    		$-0.77$-0.45-71.11%Miss-755.6%
    Dec 25
    Reported Feb 13
    		$-0.85$-0.54-57.41%Miss+71.7%
    Sep 25
    Reported Nov 10
    		$-1.25$-0.26-380.77%Miss+77.7%
    Jun 25
    Reported Aug 12
    		$-1.53$-1.32-15.91%Miss+71.7%
    Mar 25
    Reported Jun 17
    		$-0.09$-0.15+40.00%Beat+75.0%
    Dec 24
    Reported Feb 10
    		$-3.00$-3.20+6.25%Beat+70.0%
    Sep 24
    Reported Nov 11
    		$-5.60$-5.68+1.41%Beat+45.1%
    Jun 24
    Reported Aug 6
    		$-5.40$-6.35+14.96%Beat+40.0%
    Mar 24
    Reported Jun 24
    		$-0.36$-0.48+25.00%Beat+46.3%
    Dec 23
    Reported Feb 12
    		$-10.00$-10.80+7.41%Beat-16.3%
    Sep 23
    Reported Nov 13
    		$-10.20$-9.16-11.35%Miss-27.5%
    Jun 23
    Reported Aug 10
    		$-9.00$-8.10-11.11%Miss-21.6%
    Mar 23
    Reported Jun 22
    		$-0.67$-0.47-42.55%Miss+8.2%
    Dec 22
    Reported Feb 9
    		$-8.60$-8.20-4.88%Miss-48.3%
    Sep 22
    Reported Nov 8
    		$-8.00$-6.60-21.21%Miss-11.1%
    Jun 22
    Reported Aug 11
    		$-7.40$-5.93-24.79%Miss-19.4%
    Mar 22
    Reported Jun 28
    		$-0.73$-0.27-170.37%Miss-204.2%
    Dec 21
    Reported Feb 10
    		$-5.80$-5.20-11.54%Miss+12.1%
    Sep 21
    Reported Nov 11
    		$-7.20$-6.00-20.00%Miss-20.0%
    Jun 21
    Reported Aug 10
    		$-6.20$-4.28-44.86%Miss+22.5%
    Mar 21
    Reported Jun 10
    		$-0.24$-0.31+22.58%Beat+33.3%
    Dec 20
    Reported Feb 9
    		$-6.60$-6.25-5.60%Miss+23.3%
    Sep 20
    Reported Nov 11
    		$-6.00$-6.80+11.76%Beat+21.1%
    Jun 20
    Reported Aug 6
    		$-8.00$-6.25-28.00%Miss+40.3%
    Mar 20
    Reported Jun 22
    		$-0.36$-0.38+5.26%Beat-187.8%
    Dec 19
    Reported Feb 7
    		$-8.60$-6.80-26.47%Miss-490.9%
    Sep 19
    Reported Nov 6
    		$-7.60$-6.00-26.67%Miss+28.3%
    Jun 19
    Reported Aug 14
    		$-13.40$-5.60-139.29%Miss-3622.2%
    Mar 19
    Reported Jun 25
    		$0.41$0.28+46.43%Beat-85.4%
    Dec 18
    Reported Feb 13
    		$2.20N/A+148.89%Beat+139.3%
    Sep 18
    Reported Nov 14
    		$-10.60$-3.70-186.49%Miss+55.1%
    Jun 18
    Reported Aug 14
    		$-0.36$-0.29-24.14%Miss+96.1%
    Mar 18
    Reported Jun 14
    		$2.80$-5.13+154.58%Beat+393.2%
    Dec 17
    Reported Mar 19
    		$-5.60$-7.87+28.84%Beat-
    Sep 17
    Reported Nov 3
    		$-23.60$-9.53-147.64%Miss-
    Jun 17
    Reported Aug 11
    		$-9.20$-5.40-70.37%Miss-
    Mar 17
    Reported May 15
    		$-0.95N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio0.27EV/EBITDAN/A
    Price/FCF-0.08xFCF Yield-1229.44%
    Profitability
    Profit Margin0.00%Operating Margin-374.00%
    ROE-520.00%ROIC-136.35%
    Financial Health
    Debt/Equity11.22xInterest Coverage-6.05x
    Current Ratio3.31xQuick Ratio3.12x
    Trading Statistics
    Beta0.21Avg Volume83.48K
    52-Week High$53.2052-Week Low$2.05

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.41
    SMA 20$2.68
    SMA 50$3.81
    SMA 200$11.49
    EMA 10$2.39
    EMA 20$2.69
    EMA 50$3.79
    EMA 200$14.00

    MACD

    Line: -0.45Signal: -0.47Hist: 0.02

    ADX

    ADX: 26.2+DI: 11.5-DI: 25.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$2.80

    Bollinger Bands

    Upper Band$3.40
    Lower Band$1.97
    %B Position5358%(Upper)
    Band Width0.17

    RSI (14-Day)

    Neutral
    31.0

    Momentum Oscillators

    Stoch %K8.4
    Stoch %D7.0
    Williams %R-83.0
    ROC (10d)-24.6%
    Momentum-0.72
    CCI (20d)-120.9
    MFI (14d)34.0

    Volatility Measures

    ATR (14d)$0.33(14.7%)
    StdDev (20d)0.36
    Hist Vol91.2%(High)

    Volume Flow

    VWAP$2.17
    OBV546.8M
    AD Line1571.0B
    CMF (20d)0.146

    Volume Metrics

    Avg Vol (20d)90.0K
    Vol Ratio0.3x(Low)
    VWMA (20d)$2.84

    Pivot Points

    R3$2.42
    R2$2.33
    R1$2.22
    Pivot Point$2.13
    S1$2.02
    S2$1.93
    S3$1.82

    Advanced Oscillators

    TSI-39.17
    Ultimate Osc31.0
    KST-338.00

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.77M$1.91M$2.19M$1.82M$1.76M$1.15M$1.07M$798,000$683,000$470,000$391,000$239,000
    Cost of Revenue$1.54M$1.81M$1.89M$2.12M$1.60M$1.18M$1.29M$1.88M$1.02M$983,000$748,000$432,000
    Gross Profit$225,000$94,000$300,000$-298,000$156,000$-32,000$-215,000$-1,084,000$-333,000$-513,000$-357,000$-193,000
    Operating Expenses$6.84M$7.26M$6.90M$7.36M$7.77M$7.14M$10.74M$11.75M$13.25M$12.12M$16.61M$17.34M
    R&D$1.96M$2.28M$2.43M$2.45M$3.09M$3.26M$3.00M$4.58M$6.01M$5.70M$6.84M$7.13M
    SG&A$4.88M$4.99M$4.47M$4.91M$4.69M$3.88M$7.73M$7.16M$7.24M$6.42M$5.01M$10.21M
    Operating Income$-6,612,000$-7,170,000$-6,596,000$-7,661,000$-7,617,000$-7,174,000$-10,952,000$-12,833,000$-13,580,000$-12,634,000$-16,963,000$-17,535,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.49M$2.27M$1.09M$639,000$548,000$580,000$549,000$927,000$964,000$921,000$919,000$914,000
    Income Before Tax$-8,154,000$-10,368,000$-7,630,000$-8,257,999$-8,078,000$-8,063,000$-13,333,000$-14,029,000$-13,055,000$-14,556,000$-17,258,000$-17,426,000
    Income Tax Expense$0$1.01M$0$0$-387,000$0$-301,000$-671,000$-854,000$-849,000$-1,038,000$-292,000
    Net Income$-7,935,000$-10,282,000$-7,336,000$-7,940,000$-7,691,000$-8,034,000$-13,032,000$-13,358,000$-12,201,000$-13,707,000$-16,219,999$-16,220,000
    EBITDA$-5,539,000$-11,728,000$-5,650,000$-6,702,999$-6,604,000$-6,544,000$-11,928,000$-12,156,000$-11,261,000$-12,898,000$-15,683,000$-16,004,000
    EBIT$-6,459,000$-12,643,000$-6,542,000$-7,618,999$-7,530,000$-7,483,000$-12,784,000$-13,102,000$-12,091,000$-13,635,000$-16,339,000$-16,512,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XAIR

    News

    Beyond Air director Lin Yi-Chien buys $5,761 in company stock

    Beyond Air Director Lin Yi-Chien purchased 2,607 shares of the company's common stock for $5,761. This insider buy occurred while the stock is near its 52-week low and analysts view it as undervalued. The company...

    Investing.com•10/15/26•Somewhat-Bullish

    10% Owner Yi-chien Lin Buys 2,607 Shares of Beyond Air Inc (XAIR)

    Yi-chien Lin, a 10% owner of Beyond Air Inc (XAIR), recently purchased 2,607 shares, increasing their total direct ownership to 148,000 shares. This transaction follows a year-long pattern of insider buying with no...

    GuruFocus•10/15/26•Somewhat-Bullish

    Beyond Air director Lin Yi-Chien buys $5,761 in company stock By Investing.com

    Beyond Air director Lin Yi-Chien recently purchased 2,607 shares of the company's common stock for $5,761, increasing his beneficial ownership to 148,000 shares. This insider acquisition comes as the stock trades near...

    Investing.com South Africa•10/14/26•Somewhat-Bullish

    At $2.21 a share, Beyond Air (XAIR) ten percent owner Lin Yi-Chien buys 2,607 shares.

    Beyond Air (XAIR) ten percent owner Lin Yi-Chien purchased 2,607 shares of common stock at $2.21 per share on October 13...

    Stock Titan•10/14/26•Neutral

    Beyond Air preliminary revenue up 27% to USD 2.3M in Sep quarter

    Beyond Air, Inc. reported preliminary, unaudited revenue of approximately $2.3 million for the quarter ended September 30, 2026...

    Medical Buyer•10/10/26•Somewhat-Bullish

    XAIR Valuation and Fair Value

    P/E
    0.3x
    P/FCF
    -0.1x
    P/B
    0.8x
    See GNG's fair value

    XAIR Profitability: Margins, ROIC and FCF

    Gross margin
    4.2%
    Operating margin
    -374.0%
    Net margin
    0.0%
    ROIC
    -136.4%
    ROE
    -520.0%
    FCF margin
    -255.0%
    FCF yield
    -1229.4%

    XAIR Competitors

    CompanyTicker
    BioRestorative Therapies IncBRTX
    NewGenIvf Group Limited Class A Ordinary SharesNIVF
    Clearside Biomedical IncCLSD
    Purple BiotechPPBT
    Qualigen Therapeutics IncQLGN
    Nexgel IncNXGL
    Im Cannabis CorpIMCC
    Genprex IncGNPX

    Sector: Healthcare

    XAIR Bull Case vs Bear Case

    Bear case

    • XAIR has a debt-to-equity ratio of 11.2x.

    XAIR Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -31.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-3.30
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About XAIR

    Does XAIR pay dividends?

    Beyond Air Inc (XAIR) does not currently pay a regular dividend.

    What is XAIR's P/E ratio?

    Beyond Air Inc has a price-to-earnings (P/E) ratio of 0.27.

    What is XAIR's market cap?

    Beyond Air Inc (XAIR) has a market capitalization of $2.07M with a current stock price of $2.21.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In